Skip to main content
PharmaResources (Shanghai) Co., Ltd. logo

PharmaResources (Shanghai) Co., Ltd. — Investor Relations & Filings

Ticker · 301230 ISIN · CNE1000065Q9 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 458 across all filing types
Latest filing 2026-04-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 301230

About PharmaResources (Shanghai) Co., Ltd.

https://www.pharmaresources.cn

PharmaResources (Shanghai) Co., Ltd. is a comprehensive Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) specializing in small molecule drug discovery and development. The company provides an integrated platform of services including medicinal chemistry, custom synthesis, process research and development, and analytical chemistry. PharmaResources supports global pharmaceutical and biotechnology partners through the entire drug development lifecycle, from initial lead optimization to the commercial-scale manufacturing of advanced intermediates and Active Pharmaceutical Ingredients (APIs). With a focus on technical innovation and quality management, the firm utilizes advanced synthetic methodologies and process engineering to accelerate drug candidates toward clinical trials and market approval.

Recent filings

Filing Released Lang Actions
2025年度独立董事述职报告 （尤启冬）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2025 from Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. It details the independent director's duties, attendance at board and shareholder meetings, communication with auditors, oversight of internal controls, and evaluation of company governance and compliance with laws and regulations. It also discusses the director's opinions on various company matters, including related party transactions, financial reporting, appointment of auditors, and management changes. The document is a detailed report on the independent director's activities and governance oversight for the year 2025, which aligns with the category of Board/Management Information (MANG), as it focuses on board-level governance and management oversight rather than financial results or audit reports. It is not an annual report (10-K), audit report (AR), or regulatory filing (RNS), nor is it a simple announcement or presentation. The length and content confirm it is a substantive report on board/management matters.
2026-04-28 Chinese
2025年度独立董事述职报告 （程立）
Board/Management Information Classification · 95% confidence The document is titled as the "2025年度独立董事述职报告" which translates to "2025 Annual Independent Director's Work Report." It is a detailed report by an independent director about their duties, attendance, opinions, and activities during the year 2025. The content includes descriptions of board meetings, committee participation, audit oversight, communication with shareholders, and governance matters. It does not contain financial statements or quarterly/annual financial results but focuses on management and board-level information. This type of document fits best under Board/Management Information (MANG) as it relates to the activities and reports of board members rather than financial results or audit reports. The document length is sufficient and the content is substantive, not a mere announcement or certification. Therefore, the classification is MANG with high confidence.
2026-04-28 Chinese
2025年度环境、社会和治理（ESG）报告
Environmental & Social Information Classification · 100% confidence The document is titled "2025年环境、社会和治理(ESG)报告" which translates to "2025 Environmental, Social and Governance (ESG) Report." It is a comprehensive report covering the company's ESG management strategies, practices, and performance for the fiscal year 2025. The content includes governance structure, sustainability strategy, risk management, social responsibility, environmental management, and related performance metrics. It references standards such as Shenzhen Stock Exchange guidelines, GRI standards, and international sustainability frameworks. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The focus on ESG factors aligns with the definition of Environmental & Social Information (Code: SR). There is no indication that this is an announcement or a certification letter, nor is it a financial report or other filing type. Therefore, the document should be classified as Environmental & Social Information (SR).
2026-04-28 Chinese
2025年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2025年度内部控制评价报告' which translates to '2025 Internal Control Evaluation Report'. It is issued by the company's board of directors and discusses the evaluation of the company's internal control effectiveness as of December 31, 2025. The content includes detailed descriptions of internal control scope, governance structure, risk assessment, control activities, and internal control defect recognition standards. It is a comprehensive report on the company's internal control system and its effectiveness, including financial and non-financial controls. There is no indication that this is an announcement or a brief summary; rather, it is a full report. The document is not an annual report, audit report, or earnings release, but specifically an internal control evaluation report, which aligns with the category of Audit Report / Information (AR) as it relates to internal control evaluation and audit-related information. Therefore, the most appropriate classification is AR with high confidence. FY 2025
2026-04-28 Chinese
董事会薪酬与考核委员会关于2024年限制性股票激励计划首次授予部分第一个归属期归属名单的核查意见
Remuneration Information Classification · 95% confidence The document is a formal announcement from the Board's Remuneration and Assessment Committee regarding the verification of the first vesting list of a 2024 restricted stock incentive plan. It discusses compliance with relevant laws and regulations, the qualification of incentive recipients, and the approval of stock vesting. This content relates to executive compensation and stock incentive plans, which falls under remuneration information. The document is an announcement of the committee's opinion on the stock incentive plan vesting, not a full remuneration report or proxy statement. Given the focus on compensation and stock incentives, the appropriate classification is Remuneration Information (DEF 14A). The document length is short and specific to remuneration matters, supporting this classification with high confidence.
2026-04-28 Chinese
关于2024年限制性股票激励计划首次授予部分第一个归属期归属条件成就的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the achievement of vesting conditions for a restricted stock incentive plan for a specific period. It includes information about the number of shares vested, the list of eligible participants, the approval process by the board and shareholders, performance targets, and legal opinions. The document is not a full annual or interim financial report, nor is it a simple announcement of a report publication. It is not a transcript, audit report, or earnings release. It is a corporate announcement related to stock-based compensation and management incentives, specifically about the vesting of restricted stock under an incentive plan. This type of document fits best under the category of Capital/Financing Update (CAP), as it deals with equity incentives, stock grants, and related corporate actions affecting capital structure and management compensation. The document length and detail confirm it is not a brief announcement but a substantive update on the stock incentive plan vesting event.
2026-04-28 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.